Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease.

We report the case of a 34-year-old female patient who died 4 days after hospital admission of acute heart failure clinically mimicking ischemic heart disease. Microscopic examination of the heart showed severe myocarditis. Polymerase chain reaction (PCR), including quantitative real-time PCR, disclosed exclusively parvovirus B19 (PVB19), with a high viral load of 4.3x10(5) PVB19 viral genome equivalents per microg myocardial nucleic acid. Radioactive in situ hybridization detected viral genomes in endothelial cells (ECs) predominantly in the venular compartment and (to a lesser degree) in small arteries and arterioles of the heart, but not in cardiac myocytes or other tissue components. Concomitant with EC infection, marked expression of the adhesion molecule E-selectin was noted, accompanied by margination, adherence, penetration, and perivascular infiltration of T lymphocytes. We speculate that, due to the high viral load in cardiac ECs, PVB19 infection of endothelial cells was sufficient to induce impaired coronary microcirculation with secondary cardiac myocyte necrosis.

[1]  D. Reichenbach,et al.  Fatal parvovirus myocarditis in a 5-year-old girl. , 2001, Human pathology.

[2]  L. Dei Cas,et al.  Adult human heart microvascular endothelial cells are permissive for non-lytic infection by human cytomegalovirus. , 2001, Cardiovascular research.

[3]  G. d’Amati,et al.  Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  M. Raftery,et al.  Cytomegalovirus infection of vascular cells induces expression of pro-inflammatory adhesion molecules by paracrine action of secreted interleukin-1beta. , 2000, Transplantation.

[5]  R. Schoentag,et al.  Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using in situ hybridization and immunohistochemistry. , 1997, Human pathology.

[6]  W. Dippold,et al.  Human parvovirus B19 infection associated with severe acute perimyocarditis in a 34-year-old man. , 1997, European heart journal.

[7]  B. McManus,et al.  Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets , 1996, Journal of virology.

[8]  L. Anderson,et al.  Genetic diversity of human parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates. , 1996, The Journal of general virology.

[9]  J. Chia,et al.  Myopericarditis due to parvovirus B19 in an adult. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Pablo Engel,et al.  The selecting: vascular adhesion molecules , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Y. Matsunaga,et al.  Human parvovirus B19 infection: Immunohistochemical and electron microscopic studies of skin lesions , 1995, Journal of cutaneous pathology.

[12]  N. Young,et al.  Erythrocyte P antigen: cellular receptor for B19 parvovirus. , 1993, Science.

[13]  K. Klingel,et al.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Astell,et al.  In vitro identification of a B19 parvovirus promoter. , 1987, Virology.

[15]  Lloyd M. Smith,et al.  Fluorescence detection in automated DNA sequence analysis , 1986, Nature.